160 related articles for article (PubMed ID: 35209173)
1. Improved Cell-Potent and Selective Peptidomimetic Inhibitors of Protein N-Terminal Methyltransferase 1.
Dong G; Iyamu ID; Vilseck JZ; Chen D; Huang R
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209173
[TBL] [Abstract][Full Text] [Related]
2. Selective Peptidomimetic Inhibitors of NTMT1/2: Rational Design, Synthesis, Characterization, and Crystallographic Studies.
Mackie BD; Chen D; Dong G; Dong C; Parker H; Schaner Tooley CE; Noinaj N; Min J; Huang R
J Med Chem; 2020 Sep; 63(17):9512-9522. PubMed ID: 32689795
[TBL] [Abstract][Full Text] [Related]
3. Structure-based Discovery of Cell-Potent Peptidomimetic Inhibitors for Protein N-Terminal Methyltransferase 1.
Chen D; Dong G; Deng Y; Noinaj N; Huang R
ACS Med Chem Lett; 2021 Mar; 12(3):485-493. PubMed ID: 33738076
[TBL] [Abstract][Full Text] [Related]
4. Venglustat Inhibits Protein N-Terminal Methyltransferase 1 in a Substrate-Competitive Manner.
Dong G; Deng Y; Yasgar A; Yadav R; Talley D; Zakharov AV; Jain S; Rai G; Noinaj N; Simeonov A; Huang R
J Med Chem; 2022 Sep; 65(18):12334-12345. PubMed ID: 36074125
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and kinetic analysis of potent protein N-terminal methyltransferase 1 inhibitors.
Zhang G; Richardson SL; Mao Y; Huang R
Org Biomol Chem; 2015 Apr; 13(14):4149-54. PubMed ID: 25712161
[TBL] [Abstract][Full Text] [Related]
6. Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1.
Zhou Q; Wu W; Jia K; Qi G; Sun XS; Li P
Eur J Med Chem; 2022 Dec; 244():114830. PubMed ID: 36228414
[TBL] [Abstract][Full Text] [Related]
7. Structural Studies Provide New Insights into the Role of Lysine Acetylation on Substrate Recognition by CARM1 and Inform the Design of Potent Peptidomimetic Inhibitors.
Zhang Y; Marechal N; van Haren MJ; Troffer-Charlier N; Cura V; Cavarelli J; Martin NI
Chembiochem; 2021 Dec; 22(24):3469-3476. PubMed ID: 34569136
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Bisubstrate Inhibitors for Protein N-Terminal Methyltransferase 1.
Chen D; Dong G; Noinaj N; Huang R
J Med Chem; 2019 Apr; 62(7):3773-3779. PubMed ID: 30883119
[TBL] [Abstract][Full Text] [Related]
9. Probing the Plasticity in the Active Site of Protein N-terminal Methyltransferase 1 Using Bisubstrate Analogues.
Chen D; Dong C; Dong G; Srinivasan K; Min J; Noinaj N; Huang R
J Med Chem; 2020 Aug; 63(15):8419-8431. PubMed ID: 32605369
[TBL] [Abstract][Full Text] [Related]
10. Chemoproteomic Study Uncovers HemK2/KMT9 As a New Target for NTMT1 Bisubstrate Inhibitors.
Chen D; Meng Y; Yu D; Noinaj N; Cheng X; Huang R
ACS Chem Biol; 2021 Jul; 16(7):1234-1242. PubMed ID: 34192867
[TBL] [Abstract][Full Text] [Related]
11. Structure-Activity Relationship Studies of Venglustat on NTMT1 Inhibition.
Deng Y; Dong G; Meng Y; Noinaj N; Huang R
J Med Chem; 2023 Jan; 66(2):1601-1615. PubMed ID: 36634151
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for substrate recognition by the human N-terminal methyltransferase 1.
Dong C; Mao Y; Tempel W; Qin S; Li L; Loppnau P; Huang R; Min J
Genes Dev; 2015 Nov; 29(22):2343-8. PubMed ID: 26543161
[TBL] [Abstract][Full Text] [Related]
14. A stereoselective approach to peptidomimetic BACE1 inhibitors.
Butini S; Gabellieri E; Brindisi M; Giovani S; Maramai S; Kshirsagar G; Guarino E; Brogi S; La Pietra V; Giustiniano M; Marinelli L; Novellino E; Campiani G; Cappelli A; Gemma S
Eur J Med Chem; 2013; 70():233-47. PubMed ID: 24158015
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a new isomannide-based peptidomimetic synthetized by Ugi multicomponent reaction as human tissue kallikrein 1 inhibitor.
Barros TG; Santos JAN; de Souza BEG; Sodero ACR; de Souza AMT; da Silva DP; Rodrigues CR; Pinheiro S; Dias LRS; Abrahim-Vieira B; Puzer L; Muri EMF
Bioorg Med Chem Lett; 2017 Jan; 27(2):314-318. PubMed ID: 27914800
[TBL] [Abstract][Full Text] [Related]
16. Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites.
Olaleye TO; Brannigan JA; Roberts SM; Leatherbarrow RJ; Wilkinson AJ; Tate EW
Org Biomol Chem; 2014 Nov; 12(41):8132-7. PubMed ID: 25230674
[TBL] [Abstract][Full Text] [Related]
17. New substrate analogue furin inhibitors derived from 4-amidinobenzylamide.
Becker GL; Hardes K; Steinmetzer T
Bioorg Med Chem Lett; 2011 Aug; 21(16):4695-7. PubMed ID: 21757345
[TBL] [Abstract][Full Text] [Related]
18. Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors.
Trabocchi A; Pala N; Krimmelbein I; Menchi G; Guarna A; Sechi M; Dreker T; Scozzafava A; Supuran CT; Carta F
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):466-71. PubMed ID: 25198885
[TBL] [Abstract][Full Text] [Related]
19. Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase.
Butler KV; Ma A; Yu W; Li F; Tempel W; Babault N; Pittella-Silva F; Shao J; Wang J; Luo M; Vedadi M; Brown PJ; Arrowsmith CH; Jin J
J Med Chem; 2016 Nov; 59(21):9881-9889. PubMed ID: 27804297
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms for auto-inhibition and forced product release in glycine N-methyltransferase: crystal structures of wild-type, mutant R175K and S-adenosylhomocysteine-bound R175K enzymes.
Huang Y; Komoto J; Konishi K; Takata Y; Ogawa H; Gomi T; Fujioka M; Takusagawa F
J Mol Biol; 2000 Apr; 298(1):149-62. PubMed ID: 10756111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
